switching from glp 1 to tirzepatide Impact of CVS GLP-1 formulary change on prescribing switching from semaglutide to tirzepatide

Tirzepatide targets both the GLP-1 and glucagon receptors, so its a dual agonist

In the case of MET-097i, it is a GLP-1 RA analog that has an extended half-life of ~15-16 days, which is many fold that of native GLP-1 peptide and more than 2x the half-life of semaglutide (GLP-1 RA)

This was compared to 80% in the Xtandi monotherapy arm and 71.4% in the leuprolide-only cohort

For instance, a retrospective study revealed that SGLT2i reduced incidence of HHF and acute kidney injury [72]

What Should I Do if I Am Unsure Whether Ozempic Is Right for Me

If you are at the stage of deciding whether tirzepatide is the right fit for your goals, it may be helpful to see if you qualify for a personalized program